المؤلفون: Drawnel, FM, Boccardo, S, Prummer, M, Delobel, F, Graff, A, Weber, M, Gerard, R, Badi, L, Kam-Thong, T, Bu, L, Jiang, X, Hoflack, JC, Kiialainen, A, Jeworutzki, E, Aoyama, N, Carlson, C, Burcin, M, Gromo, G, Boehringer, M, Stahlberg, H, Hall, BJ, Magnone, MC, Kolaja, K, Chien, KR, Bailly, J, Iacone, R

المصدر: Cell reports. 9(3):810-820

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:130079598

المؤلفون: Clerc RG, Stauffer A, Weibel F, Hainaut E, Perez A, Hoflack JC, Bénardeau A, Pflieger P, Garriz JM, Funder JW, Capponi AM, Niesor EJ

المصدر: Journal of Hypertension; 2010 Aug, Vol. 28 Issue 8, p1676-1686, 11p

المؤلفون: Bosch M; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Kallin N; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Donakonda S; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Zhang JD; Roche Pharmaceutical Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland., Wintersteller H; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Hegenbarth S; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Heim K; Third Department of Medicine, University Hospital Freiburg, Freiburg, Germany., Ramirez C; Health Data Science Unit, Biomedical Genomics Group, Bioquant, Faculty of Medicine Heidelberg, Heidelberg, Germany., Fürst A; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Lattouf EI; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Feuerherd M; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Chattopadhyay S; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Kumpesa N; Roche Pharmaceutical Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland., Griesser V; Roche Pharmaceutical Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland., Hoflack JC; Roche Pharmaceutical Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland., Siebourg-Polster J; Roche Pharmaceutical Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland., Mogler C; Institute of Pathology, School of Medicine and Health, TUM, Munich, Germany., Swadling L; Division of Infection and Immunity, Institute of Immunity and Transplantation, University College London, London, UK., Pallett LJ; Division of Infection and Immunity, Institute of Immunity and Transplantation, University College London, London, UK., Meiser P; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Manske K; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., de Almeida GP; Institute of Immunology and Animal Physiology, School of Life Science, TUM, Munich, Germany., Kosinska AD; Institute of Virology, School of Medicine and Health, TUM, Munich, Germany.; Helmholtz Zentrum München, Munich, Germany.; German Center for Infection Research, Munich site, Munich, Germany., Sandu I; Institute of Microbiology, ETH Zürich, Zürich, Switzerland., Schneider A; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Steinbacher V; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Teng Y; Institute of Virology, School of Medicine and Health, TUM, Munich, Germany., Schnabel J; Institute of Machine Learning and Biomedical Imaging, Helmholtz Zentrum Munich, Munich, Germany., Theis F; Institute of Computational Biology, TUM, Munich, Germany., Gehring AJ; Toronto Centre for Liver Disease and Toronto General Hospital Research Institute, Toronto, Ontario, Canada.; Department of Immunology, University of Toronto, Toronto, Ontario, Canada., Boonstra A; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands., Janssen HLA; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.; Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada., Vandenbosch M; Institute of Multimodal Imaging, University of Maastricht, Maastricht, The Netherlands., Cuypers E; Institute of Multimodal Imaging, University of Maastricht, Maastricht, The Netherlands., Öllinger R; Institute of Molecular Oncology and Functional Genomics, School of Medicine and Health, TUM, Munich, Germany., Engleitner T; Institute of Molecular Oncology and Functional Genomics, School of Medicine and Health, TUM, Munich, Germany., Rad R; Institute of Molecular Oncology and Functional Genomics, School of Medicine and Health, TUM, Munich, Germany., Steiger K; Comparative Experimental Pathology, School of Medicine and Health, TUM, Munich, Germany., Oxenius A; Institute of Microbiology, ETH Zürich, Zürich, Switzerland., Lo WL; Department of Pathology, University of Utah, Salt Lake City, UT, USA., Klepsch V; Institute of Cell Genetics, Medical University of Innsbruck, Innsbruck, Austria., Baier G; Institute of Cell Genetics, Medical University of Innsbruck, Innsbruck, Austria., Holzmann B; Department of Surgery, School of Medicine and Health, TUM, Munich, Germany., Maini MK; Institute of Pathology, School of Medicine and Health, TUM, Munich, Germany., Heeren R; Institute of Multimodal Imaging, University of Maastricht, Maastricht, The Netherlands., Murray PJ; Max Planck Institute of Biochemistry, Martinsried, Munich, Germany., Thimme R; Third Department of Medicine, University Hospital Freiburg, Freiburg, Germany., Herrmann C; Health Data Science Unit, Biomedical Genomics Group, Bioquant, Faculty of Medicine Heidelberg, Heidelberg, Germany.; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Protzer U; Institute of Immunology and Animal Physiology, School of Life Science, TUM, Munich, Germany.; Institute of Virology, School of Medicine and Health, TUM, Munich, Germany.; Helmholtz Zentrum München, Munich, Germany., Böttcher JP; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Zehn D; Institute of Immunology and Animal Physiology, School of Life Science, TUM, Munich, Germany., Wohlleber D; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Lauer GM; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Hofmann M; Third Department of Medicine, University Hospital Freiburg, Freiburg, Germany., Luangsay S; Roche Pharmaceutical Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland., Knolle PA; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany. percy.knolle@tum.de.; German Center for Infection Research, Munich site, Munich, Germany. percy.knolle@tum.de.; Institute of Molecular Immunology, School of Life Science, TUM, Munich, Germany. percy.knolle@tum.de.

المصدر: Nature [Nature] 2024 Jul 10. Date of Electronic Publication: 2024 Jul 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

المؤلفون: Nudischer R; Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, 4070 Basel, Switzerland., Renggli K; Bioengineering Laboratory, Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Bertinetti-Lapatki C; Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, 4070 Basel, Switzerland., Hoflack JC; Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, 4070 Basel, Switzerland., Flint N; Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, 4070 Basel, Switzerland., Sewing S; Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, 4070 Basel, Switzerland., Pedersen L; Roche Pharma Research and Early Development, Roche Innovation Center Copenhagen, 2970 Hørsholm, Denmark., Schadt S; Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, 4070 Basel, Switzerland., Higgins LG; CXR Biosciences Ltd, Dundee DD1 5JJ, Scotland, UK., Vardy A; CXR Biosciences Ltd, Dundee DD1 5JJ, Scotland, UK., Lenz B; Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, 4070 Basel, Switzerland., Gand L; Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, 4070 Basel, Switzerland., Boess F; Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, 4070 Basel, Switzerland., Elcombe BM; CXR Biosciences Ltd, Dundee DD1 5JJ, Scotland, UK., Hierlemann A; Bioengineering Laboratory, Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland., Roth AB; Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, 4070 Basel, Switzerland.

المصدر: Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2020 Aug 01; Vol. 176 (2), pp. 329-342.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9805461 Publication Model: Print Cited Medium: Internet ISSN: 1096-0929 (Electronic) Linking ISSN: 10960929 NLM ISO Abbreviation: Toxicol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Receptors, Steroid*, Imidazoles/*pharmacology , Pyridines/*pharmacology , Receptors, Cytoplasmic and Nuclear/*agonists, Animals ; Constitutive Androstane Receptor ; Hepatocytes ; Humans ; Liver ; Macaca fascicularis ; Mice ; Mice, Inbred C57BL ; Organoids

المؤلفون: Jacobsen B; 1 Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Switzerland., Freichel C; 1 Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Switzerland., Eichinger-Chapelon A; 1 Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Switzerland., Brink A; 1 Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Switzerland., Hoflack JC; 1 Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Switzerland., Albassam M; 2 Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center New York, NY, USA., Lenz B; 1 Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Switzerland.

المصدر: Toxicologic pathology [Toxicol Pathol] 2019 Feb; Vol. 47 (2), pp. 138-149. Date of Electronic Publication: 2018 Dec 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 7905907 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-1601 (Electronic) Linking ISSN: 01926233 NLM ISO Abbreviation: Toxicol Pathol Subsets: MEDLINE

مواضيع طبية MeSH: Alpha-Globulins/*metabolism , Enzyme Inhibitors/*toxicity , Kidney Diseases/*chemically induced , Kidney Diseases/*metabolism, Animals ; Female ; Kidney Diseases/pathology ; Male ; Neuroprotective Agents/toxicity ; Rats ; Rats, Wistar

المؤلفون: Vahle JL; Lilly Research Laboratories, Indianapolis, IN, USA. Electronic address: jvahle@lilly.com., Anderson U; AstraZeneca, Drug Safety & Metabolism, Mölndal, Sweden., Blomme EAG; AbbVie, Global Preclinical Safety, North Chicago, IL, USA., Hoflack JC; F Hoffmann La Roche, Pharma Research and Early Development, Roche Innovation Center Basel, CH, Switzerland., Stiehl DP; Novartis Pharma AG, Translational Medicine at the Novartis Institutes of Biomedical Research, Basel, Switzerland.

المصدر: Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 2018 Jul; Vol. 96, pp. 18-29. Date of Electronic Publication: 2018 Apr 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8214983 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0295 (Electronic) Linking ISSN: 02732300 NLM ISO Abbreviation: Regul Toxicol Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Drug Industry* , Toxicogenetics*, Drug Evaluation, Preclinical/*adverse effects, Animals ; Humans

المؤلفون: Mueller H; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland., Wildum S; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland., Luangsay S; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland., Walther J; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland., Lopez A; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland., Tropberger P; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland., Ottaviani G; Roche Pharma Research and Early Development, Roche Innovation Center Shanghai, Shanghai 201203, China., Lu W; Roche Pharma Research and Early Development, Roche Innovation Center Shanghai, Shanghai 201203, China., Parrott NJ; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland., Zhang JD; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland., Schmucki R; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland., Racek T; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland., Hoflack JC; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland., Kueng E; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland., Point F; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland., Zhou X; Roche Pharma Research and Early Development, Roche Innovation Center Shanghai, Shanghai 201203, China., Steiner G; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland., Lütgehetmann M; Department of Internal Medicine and Institute of Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Rapp G; Department of Internal Medicine and Institute of Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Volz T; Department of Internal Medicine and Institute of Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Dandri M; Department of Internal Medicine and Institute of Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Yang S; Roche Pharma Research and Early Development, Roche Innovation Center Shanghai, Shanghai 201203, China., Young JAT; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland. Electronic address: john.young.jy3@roche.com., Javanbakht H; Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland. Electronic address: ajbakht@gmail.com.

المصدر: Journal of hepatology [J Hepatol] 2018 Mar; Vol. 68 (3), pp. 412-420. Date of Electronic Publication: 2017 Oct 25.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0641 (Electronic) Linking ISSN: 01688278 NLM ISO Abbreviation: J Hepatol Subsets: MEDLINE

مواضيع طبية MeSH: Antiviral Agents*/administration & dosage , Antiviral Agents*/adverse effects , Antiviral Agents*/pharmacokinetics , Hepatitis B virus*/drug effects , Hepatitis B virus*/genetics , Hepatitis B, Chronic*/drug therapy , Hepatitis B, Chronic*/virology , Small Molecule Libraries*/administration & dosage , Small Molecule Libraries*/adverse effects , Small Molecule Libraries*/pharmacokinetics, Gene Expression Regulation, Viral/*drug effects, Administration, Oral ; Animals ; Biological Availability ; DNA, Viral/isolation & purification ; Disease Models, Animal ; Mice ; Treatment Outcome ; Viral Load/drug effects

المؤلفون: Melo E; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel 4070, Switzerland. Electronic address: esther.melo@roche.com., Oertle P; Biozentrum and the Swiss Nanoscience Institute, University of Basel, Basel 4056, Switzerland., Trepp C; Department of Ophthalmology, Department of Clinical Research, Inselspital, Bern University Hospital, University of Bern, Bern 3010, Switzerland., Meistermann H; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel 4070, Switzerland., Burgoyne T; Institute of Ophthalmology, University College London, London EC1V9EL, United Kingdom., Sborgi L; Biozentrum and the Swiss Nanoscience Institute, University of Basel, Basel 4056, Switzerland., Cabrera AC; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel 4070, Switzerland., Chen CY; Institute of Molecular Medicine and Cell Research, University of Freiburg, Freiburg D-79104, Germany., Hoflack JC; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel 4070, Switzerland., Kam-Thong T; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel 4070, Switzerland., Schmucki R; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel 4070, Switzerland., Badi L; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel 4070, Switzerland., Flint N; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel 4070, Switzerland., Ghiani ZE; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel 4070, Switzerland., Delobel F; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel 4070, Switzerland., Stucki C; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel 4070, Switzerland., Gromo G; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel 4070, Switzerland., Einhaus A; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel 4070, Switzerland., Hornsperger B; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel 4070, Switzerland., Golling S; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel 4070, Switzerland., Siebourg-Polster J; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel 4070, Switzerland., Gerber F; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel 4070, Switzerland., Bohrmann B; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel 4070, Switzerland., Futter C; Institute of Ophthalmology, University College London, London EC1V9EL, United Kingdom., Dunkley T; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel 4070, Switzerland., Hiller S; Biozentrum and the Swiss Nanoscience Institute, University of Basel, Basel 4056, Switzerland., Schilling O; Institute of Molecular Medicine and Cell Research, University of Freiburg, Freiburg D-79104, Germany; BIOSS Centre for Biological Signaling Studies, University of Freiburg, Freiburg D-79104, Germany., Enzmann V; Department of Ophthalmology, Department of Clinical Research, Inselspital, Bern University Hospital, University of Bern, Bern 3010, Switzerland., Fauser S; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel 4070, Switzerland., Plodinec M; Biozentrum and the Swiss Nanoscience Institute, University of Basel, Basel 4056, Switzerland. Electronic address: marija.plodinec@unibas.ch., Iacone R; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel 4070, Switzerland. Electronic address: roberto.iacone47@gmail.com.

المصدر: EBioMedicine [EBioMedicine] 2018 Jan; Vol. 27, pp. 258-274. Date of Electronic Publication: 2017 Dec 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE

مواضيع طبية MeSH: Cell Polarity* , Models, Biological*, High-Temperature Requirement A Serine Peptidase 1/*metabolism , Macular Degeneration/*metabolism , Macular Degeneration/*pathology , Retinal Pigment Epithelium/*metabolism , Retinal Pigment Epithelium/*pathology , Tubulin/*metabolism, Adherens Junctions/metabolism ; Adult ; Fetus/metabolism ; High-Temperature Requirement A Serine Peptidase 1/genetics ; Humans ; Microtubules/metabolism ; Mutation/genetics ; Nanoparticles/chemistry ; Phagocytosis ; Polymerization ; Protein Aggregates ; Protein Binding ; Transcription, Genetic

المؤلفون: Polonchuk L; Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, 4070, Switzerland., Chabria M; Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, 4070, Switzerland., Badi L; Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, 4070, Switzerland., Hoflack JC; Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, 4070, Switzerland., Figtree G; Sydney Medical School, University of Sydney, Sydney, 2000, Australia., Davies MJ; Department of Biomedical Sciences, Panum Institute, University of Copenhagen, Copenhagen, 2200, Denmark., Gentile C; Sydney Medical School, University of Sydney, Sydney, 2000, Australia. carmine.gentile@sydney.edu.au.; Heart Research Institute, Newtown, 2041, Australia. carmine.gentile@sydney.edu.au.; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA. carmine.gentile@sydney.edu.au.

المصدر: Scientific reports [Sci Rep] 2017 Aug 01; Vol. 7 (1), pp. 7005. Date of Electronic Publication: 2017 Aug 01.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Heart/*physiology , Spheroids, Cellular/*physiology, Antineoplastic Agents/toxicity ; Cell Survival/drug effects ; Doxorubicin/toxicity ; Endothelial Cells/drug effects ; Endothelial Cells/physiology ; Fibroblasts/drug effects ; Fibroblasts/physiology ; Heart/drug effects ; Humans ; Models, Biological ; Myocytes, Cardiac/drug effects ; Myocytes, Cardiac/physiology ; Spheroids, Cellular/drug effects

المؤلفون: Moll S; Institute of Clinical Pathology, University Hospital Geneva, Geneva, Switzerland., Ebeling M, Weibel F, Farina A, Araujo Del Rosario A, Hoflack JC, Pomposiello S, Prunotto M

المصدر: PloS one [PLoS One] 2013; Vol. 8 (2), pp. e56575. Date of Electronic Publication: 2013 Feb 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Epithelial Cells/*pathology , Kidney Tubules/*pathology, Cell Line ; Cellular Microenvironment/drug effects ; Cisplatin/pharmacology ; Coculture Techniques ; Epithelial Cells/drug effects ; Fibrosis ; Humans